retatrutide trial update The numbers from Lilly's Phase 3 dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Eli Lilly infiltrates anti-obesity market

Addressing analysts on the companys quarterly earnings call Wednesday, Patrik Jonsson, Executive Vice President

External resources New England Journal of Medicine: Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2 trial) PMC: Switching between GLP-1 receptor agonists, rationale and practical guidance Endocrine Practice: Switching to tirzepatide from GLP-1 receptor agonists, clinical expectations PMC: The risk of vestibular disorders with semaglutide and tirzepatide In case I do not see you, good afternoon, good evening, and good night

Stay hydrated and maintain balanced meals in the days before your first injection

At Spectra Wellness, We Are Here for You We understand that no two people are the same

New immunometabolic strategy based on cell type-specific metabolic reprogramming in the tumor immune microenvironment

Jazmyn: I had very hard scar tissue above my C-section scar that I called my bubble and thought it could not be removed without surgery